Jean Dausset dies

The French immunologist Jean Dausset, who won a Nobel Prize for his discovery of human leukocyte antigens (HLAs), key components of the human immune system, died on June 6 in Mallorca, Spain, where he had lived for the past two years. He was 92. Image: Foundation Jean Dausset-CEPH"He was really a very remarkable character," linkurl:Jean-Paul Soulillou,;http://www.fondation-centaure.org/fr/fondation/documents/CvJean-PaulSoulillou.pdf a transplantation researcher at the University of Nantes who c

Written byElie Dolgin
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
The French immunologist Jean Dausset, who won a Nobel Prize for his discovery of human leukocyte antigens (HLAs), key components of the human immune system, died on June 6 in Mallorca, Spain, where he had lived for the past two years. He was 92.
Image: Foundation Jean Dausset-CEPH
"He was really a very remarkable character," linkurl:Jean-Paul Soulillou,;http://www.fondation-centaure.org/fr/fondation/documents/CvJean-PaulSoulillou.pdf a transplantation researcher at the University of Nantes who collaborated occasionally with Dausset, told __The Scientist__. "He was someone who was very elegant in his way of thinking -- very simple, very human, and very nice to know." Dausset's most notable achievement was his 1958 discovery of cell surface markers -- later called HLAs -- that help a person's immune system distinguish between the body's own cells and foreign tissues. The work, which was published in__ linkurl:Acta Haematologica,;http://www.the-scientist.com/article/display/54792/ __has been cited more than 250 times, according to ISI. This discovery paved the way for safer organ transplants by allowing clinicians to match donor and recipient cell types quickly and cheaply by simple blood tests, rather than through more complicated skin grafts. HLA genes also proved important in understanding autoimmune diseases, such as multiple sclerosis and HIV, and in tracking genetic ancestry. "A key aspect of Dausset's contribution was his insight that one would only unravel the secrets of such a diverse group of genes by analyzing large numbers of family pedigrees," linkurl:Danny Altmann,;http://www1.imperial.ac.uk/medicine/people/d.altmann/ an immunologist at Imperial College London, told the__ linkurl:Telegraph.;http://www.telegraph.co.uk/news/obituaries/medicine-obituaries/5614120/Professor-Jean-Dausset.html __Dausset also showed that genetic factors underlie the production of antibodies in blood transfusion recipients and demonstrated the link between graft efficiency and tissue compatibility. Dausset shared the linkurl:1980 Nobel Prize for Physiology or Medicine;http://nobelprize.org/nobel_prizes/medicine/laureates/1980/index.html with two US-based immunologists, linkurl:George Snell;http://nobelprize.org/nobel_prizes/medicine/laureates/1980/snell-autobio.html and Baruj Benacerraf, for this work. Born on October 19, 1916, in Toulouse, France, Dausset earned a bachelor's degree at the Lycée Michelet in Paris and studied medicine at the University of Paris in the late 1930s. During World War II, he served in North Africa, where he performed blood transfusions and developed an interest in the intersection between the immune and blood systems. Over the years, Dausset worked at the French National Blood Transfusion Center, the Paris General Hospital System, the University of Paris, the Collège de France, and the French National Institute of Health and Medical Research. In 1984, Dausset used his Nobel Prize money to establish the linkurl:Center for Study of Human Polymorphisms;http://www.cephb.fr/ (CEPH), later renamed the Foundation Jean Dausset-CEPH, which created the linkurl:first comprehensive physical map;http://www.nature.com/nature/journal/v366/n6456/abs/366698a0.html of the human genome. In 1990, Dausset and his colleagues published a linkurl:paper;http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WG1-4DNHPNC-8S&_user=10&_coverDate=03%2F31%2F1990&_rdoc=23&_fmt=high&_orig=browse&_srch=doc-info(%23toc%236809%231990%23999939996%23526012%23FLP%23display%23Volume)&_cdi=6809&_sort=d&_docanchor=&_ct=23&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=58e109c22a90af77fecbb15ad7909d05 in __Genomics__ describing the CEPH and its collaborative vision to mapping the human genome -- this study has been cited more than 400 times, according to ISI. "[Dausset] set a standard for cooperative sharing in science with the goal of helping others that has truly revolutionized the ways in which we do our work," the CEPH wrote in a linkurl:statement.;http://www.cephb.fr/en/index.php "He was very involved in promoting and defending research among universities," said Soulillou, "and he has been instrumental in inventing new institutions and organizations for research" in France.
**__Related stories:__***linkurl:50 years ago in immunology;http://www.the-scientist.com/article/display/54792/
[July 2008]*linkurl:Human genome mapping;http://www.the-scientist.com/article/display/17094/
[8th July 1996]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform